IASLC #WCLC2025 is upon us! Your co-chairs cannot wait to welcome you #NoemiReguart 🇪🇸 #IsabelleOpitz🇨🇭 #UmbertoMalapelle 🇮🇹 & a familiar face from🇮🇪

Registration & abstract submissions are OPEN!

Join us in Barcelona | Sept 6–9, 2025 @iaslc.bsky.social @oncoalert.bsky.social #LCSM bit.ly/IASLCWCLC

Delighted to host @medsir.bsky.social today at #BeaumontRCSICancerCentre, exploring novel ways to develop & expand investigator initiated trials for cancer in Ireland 🇮🇪, through @cancertrialsie.bsky.social & beyond

Welcome @medsir.bsky.social

@rcsi.bsky.social #LCSM

Early detection of lung cancer showcased at #BeaumontHospital GP study day today by #DanielJRyan, ahead of the start of the Beaumont-RCSI-Irish Cancer Society Lung Health Check Pilot Trial, opening this year

#EuropeLung #ERS #LungAmbition #RCSI #LCSM

Are you a European clinician🇪🇺 who treats pts with IO & manages #irAEs? Join us in creating a pan-European vision for #irAE care🌍

Complete this short set of q’s on irAE care in your institution & country: vub.fra1.qualtrics.com/jfe/form/SV_...

@oncoalert.bsky.social

A privilege to be part of the ESMO Women for Oncology Committee!

A snapshot of members & the important themes fostered this year: community, leadership, support 🌍

Watch this space for new creative content & events in 2025 🏆 @elinardou.bsky.social @solangepeters.bsky.social

#ESMOImmuno24
Proffered paper🔥

Ph III CM73L: Nivo+cCRT➡️consol Nivo/Ipi v Nivo v cCRT➡️Durva @solangepeters.bsky.social

- no PFS/OS benefit
- g3+TRAE 57%, 54%, 49%
- concerning pneumonitis signal

Concurrent RT+IO - going going gone
@oncoalert.bsky.social #LCSM #Medsky #Oncsky

#ESMOImmuno24
Proffered paper🔥

Gut microbiome in Ph III NIPPON trial (N/I/chemo v Pembro/chemo 1L) #JCOG

- Fusicatenibacter, Butyricicoccus = ⬆️ OS (esp with N+I: HR 0.56, 0.52) & ⬇️severe irAEs
- Blautia = ⬆️OS
- Prevotella species = ⬇️OS with N+I

@oncoalert.bsky.social #MedSky #OncSky #LCSM

#Gathering24
@mskcancercenter.bsky.social reunion!

Welcome @adamjschoenfeld.bsky.social & #AlexShoushtari. Great talks on advances in cell therapy for NSCLC & melanoma, at the Gathering around Cancer in Dublin ☘️

@mskcancercenter.bsky.social #RoisinOCearbhail #MeganGreally #JohnMcCaffrey

#Gathering24
Superb 🇮🇪young investigator session at the Gathering in Cancer meeting, in Dublin today:

- ctDNA in NSCLC @davidoreilly.bsky.social #beaumontrcsi
- melanoma #SarahLochrin #mskcc
- GI cancer #TimOBrien
- oncogene+ NSCLC @drdavidmcmahon.bsky.social
- HCC #harryharvey

Well done all🏆

Superb opinion piece on PCI in SCLC: do we need it in the IO era?

Key points:
- PCI optional in ES SCLC IO trials
- MRI surveillance acceptable in non IO era
- in LS SCLC, Adriatic showed PCI beneficial in IO & non IO arms

#LCSM #MedSky #OncSky

www.sciencedirect.com/science/arti...

Great to see our young ones at the ESMO Lung Preceptorship 🫁 🇫🇷

Thanks #ESMO for your commitment to training the next generation 🇮🇪

#LCSM